Alternative Data for Penumbra
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 62 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 54,000 | Sign up | Sign up | Sign up |
| Employee Rating | 58 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 39 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,097 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,022 | Sign up | Sign up | Sign up |
| X Followers | 4,174 | Sign up | Sign up | Sign up |
| X Mentions | 23 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 4,060 | Sign up | Sign up | Sign up |
| News Mentions | 3 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 45 | Sign up | Sign up | Sign up |
| Linkedin Employees | 3,003 | Sign up | Sign up | Sign up |
About Penumbra
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally.
| Price | $336.74 |
| Target Price | Sign up |
| Volume | 947,523 |
| Market Cap | $13.3B |
| Year Range | $225.54 - $359.4 |
| Dividend Yield | 0% |
| PE Ratio | 75.25 |
| Analyst Rating | 75% buy |
| Industry | Medical Devices |
In the news
 |
30% off Penumbra Strings at Pulse AudioMarch 9 - Pulse.audio |
Halper Sadeh LLC is Investigating Whether PEN, BCO, AES are Obtaining Fair Deals for their ShareholdersMarch 3 - GlobeNewswire |
|
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—THR, PEN, BCO, and ALGTMarch 3 - GlobeNewswire |
|
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—PEN, STKL, LNKB, and VCICMarch 2 - GlobeNewswire |
|
 |
CLPBY or PEN: Which Is the Better Value Stock Right Now?February 24 - Yahoo |
 |
Penumbra Inc (NYSE:PEN) Combines Strong Fundamentals with Bullish Technical SetupFebruary 23 - ChartMill |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 355M | 114M | 240M | 46M | 55M | 0.970 |
| Q2 '25 | 339M | 115M | 224M | 45M | 51M | 1.150 |
| Q1 '25 | 324M | 108M | 216M | 39M | 49M | 0.830 |
| Q4 '24 | 316M | 105M | 211M | 34M | 49M | 0.970 |
| Q3 '24 | 301M | 101M | 200M | 30M | 44M | 0.850 |
Insider Transactions View All
| Yuen Maggie filed to sell 18,353 shares at $342.3. March 4 '26 |
| Grewal Harpreet filed to sell 8,230 shares at $312.6. January 8 '26 |
| Bose Arani filed to sell 265,962 shares at $308. December 15 '25 |
| Bose Arani filed to sell 265,966 shares at $307.1. December 15 '25 |
Similar companies
Read more about Penumbra (PEN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Penumbra
The Market Cap of Penumbra is $13.3B.
As of today, Penumbra's PE (Price to Earnings) ratio is 75.25.
Currently, the price of one share of Penumbra stock is $336.74.
The PEN stock price chart above provides a comprehensive visual representation of Penumbra's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Penumbra shares. Our platform offers an up-to-date PEN stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Penumbra (PEN) does not offer dividends to its shareholders. Investors interested in Penumbra should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Penumbra are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
